|Articles|April 28, 2011

CTI Clinical Trial and Consulting Services Announces the Formation of CTI Clinical Trial and Consulting Services Spain SL

CTI Clinical Trial and Consulting Services

(CTI) announces the formation of CTI Clinical Trial and Consulting Services Spain, SL.  This new geographic office location will allow CTI to better meet the needs of its sponsors throughout Europe.  Spain has always been a key contributor to the clinical research field and, in recent years, has seen an increase in the number of clinical trials conducted in the country.  The new CTI office will be located in Madrid.
 
“The pharmaceutical and biotechnology industries continue to be very interested in conducting clinical research in Spain due to the quality of the clinical sites, the investigators, and the data they provide,” states Timothy J. Schroeder, CTI President and CEO.  “Our therapeutic areas mesh well with the type of research conducted in Spain and our new office will help us better meet the needs of our sponsors.” The CTI Madrid Office complements its clinical trial services offering in Western Europe. CTI’s EU Team, with headquarters in Ulm, Germany,  has managed clinical trials in multiple EU countries for many years.
 
CTI has been working for more than a decade in the drug development industry in North America, Europe, and South America, specializing in clinical research programs involving critically ill patient populations.


Related to this article

© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.